|
Volumn 126, Issue 4, 2014, Pages 305-313
|
Fragment-based design for the development of n-domain-selective angiotensin-1-converting enzyme inhibitors
|
Author keywords
Angiotensin 1 converting enzyme (ACE); Crystal structure; In silico screening; Inhibitor design; Kinetics; Rxp407
|
Indexed keywords
1X 0802;
2B 004;
33RE;
AF 399;
BTB 08399;
CA 4124;
CAPTOPRIL;
DIPEPTIDYL CARBOXYPEPTIDASE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ENALAPRILAT;
HC 6004;
HYDROXYL GROUP;
JCC 0014;
LISINOPRIL;
RAMIPRILAT;
RXP 407;
UNCLASSIFIED DRUG;
ARTICLE;
CRYSTAL STRUCTURE;
FIBROSIS;
HUMAN;
HYDROGEN BOND;
PRIORITY JOURNAL;
PROTEIN PURIFICATION;
TISSUE INJURY;
X RAY CRYSTALLOGRAPHY;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
BINDING SITES;
BLOOD PRESSURE;
DRUG DESIGN;
OLIGOPEPTIDES;
PEPTIDYL-DIPEPTIDASE A;
PHOSPHINIC ACIDS;
PROTEIN CONFORMATION;
|
EID: 84886673811
PISSN: 01435221
EISSN: None
Source Type: Journal
DOI: 10.1042/CS20130403 Document Type: Article |
Times cited : (42)
|
References (4)
|